[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 3258 Reported in Senate (RS)]
<DOC>
Calendar No. 559
119th CONGRESS
2d Session
S. 3258
[Report No. 119-140]
To require the Administrator of the Federal Aviation Administration to
publish the list of medications that the Administrator has compiled for
purposes of the medical certification of airmen and air traffic control
specialists, and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
November 20, 2025
Ms. Duckworth (for herself, Mr. Hoeven, Mr. Durbin, Mrs. Britt, Mr.
Hickenlooper, and Mr. Risch) introduced the following bill; which was
read twice and referred to the Committee on Commerce, Science, and
Transportation
September 14, 2026
Reported by Mr. Cruz, with an amendment
[Strike out all after the enacting clause and insert the part printed
in italic]
_______________________________________________________________________
A BILL
To require the Administrator of the Federal Aviation Administration to
publish the list of medications that the Administrator has compiled for
purposes of the medical certification of airmen and air traffic control
specialists, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
<DELETED>SECTION 1. SHORT TITLE.</DELETED>
<DELETED> This Act may be cited as the ``Aviation Medication
Transparency Act of 2025''.</DELETED>
<DELETED>SEC. 2. AVIATION MEDICATION TRANSPARENCY; LIST OF APPROVED
MEDICATIONS.</DELETED>
<DELETED> (a) Purpose.--The purpose of this Act is to ensure that
aviation stakeholders, including airmen, air traffic control
specialists, and individuals training to become airmen or air traffic
control specialists, who are applicants for medical certification are
informed, in a user-friendly and accessible manner, of the medications
they may be safely prescribed.</DELETED>
<DELETED> (b) In General.--Not later than 1 year after the date of
enactment of this Act, the Administrator of the Federal Aviation
Administration (in this section referred to as the ``Administrator'')
shall publish and maintain on a publicly available website of the
Federal Aviation Administration (in this section referred to as the
``FAA'') a list of medications that the Administrator, as of the date
of publication, has--</DELETED>
<DELETED> (1) determined may be safely prescribed to an
applicant for medical certification to treat certain medical
conditions; and</DELETED>
<DELETED> (2) approved for purposes of the issuance of a
medical certification to an airman or air traffic control
specialist.</DELETED>
<DELETED> (c) Requirements.--To ensure medical appropriateness,
user-friendliness, and appropriate dissemination, the list required
under subsection (b) shall--</DELETED>
<DELETED> (1) be drafted in consultation with--</DELETED>
<DELETED> (A) the Aeromedical Innovation and
Modernization Working Group (established under section
411(a) of the FAA Reauthorization Act of 2024 (49
U.S.C. 44703 note)) (in this section referred to as the
``Working Group'');</DELETED>
<DELETED> (B) institutions of higher education that
are accredited by the Aviation Accreditation Board
International;</DELETED>
<DELETED> (C) the certified exclusive bargaining
representatives of air traffic controllers of the FAA
certified under section 7111 of title 5, United States
Code;</DELETED>
<DELETED> (D) organizations representing certified
collective bargaining representative of airline pilots;
and</DELETED>
<DELETED> (E) any other stakeholder determined
relevant by the Working Group;</DELETED>
<DELETED> (2) cover all medications approved by the
Administrator, including prescription medications and over-the-
counter medications;</DELETED>
<DELETED> (3) be drafted in a user-friendly and accessible
manner and provided to airmen, air traffic control specialists,
and individuals training to become airmen or air traffic
control specialists at the time when any such individual first
seeks a medical certification;</DELETED>
<DELETED> (4) if applicable, indicate the minimum and
average period of time an airman or air traffic control
specialist is required to have limited or no duties to
stabilize on an approved medication;</DELETED>
<DELETED> (5) include the list of medications that the
Administrator has designated as ``Do Not Issue'';</DELETED>
<DELETED> (6) include information for doctors or medical
providers to contact the FAA regarding questions related to
such list, including through a new or existing mechanism that
is accessible to such doctors and medical providers;</DELETED>
<DELETED> (7) include any additional information that the
Administrator determines is appropriate to provide with respect
to what conditions a certain medication may or may not be used
to treat, as well as any information to explain why a
medication is allowed or prohibited by the FAA; and</DELETED>
<DELETED> (8) include any other information or clarification
that the Administrator determines appropriate.</DELETED>
<DELETED> (d) Annual Update.--Not later than 1 year after the date
of publication of the list required under subsection (b), and annually
thereafter, the Administrator shall update such list, as
appropriate.</DELETED>
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Aviation Medication Transparency Act
of 2026''.
SEC. 2. AVIATION MEDICATION TRANSPARENCY; LIST OF APPROVED MEDICATIONS.
(a) Purpose.--The purpose of this Act is to ensure that aviation
stakeholders, including airmen, air traffic control specialists, and
individuals training to become airmen or air traffic control
specialists, who are applicants for medical certification or medical
clearance, are informed, in a user-friendly and accessible manner, of--
(1) the medications on the ``Do Not Issue'' or ``Do Not
Fly'' lists;
(2) the medications they may safely purchase over-the-
counter or be prescribed; and
(3) under what conditions the medications described in
paragraph (2) may be safely used in the aviation environment,
consistent with the information provided in the Guide for
Aviation Medical Examiners (including any update to such
Guide), which is updated monthly, or successor documents issued
by the Federal Air Surgeon.
(b) In General.--Not later than 1 year after the date of enactment
of this Act, the Administrator of the Federal Aviation Administration
(in this section referred to as the ``Administrator'') shall publish
and maintain on a publicly available website of the Federal Aviation
Administration (in this section referred to as the ``FAA'') a list of
medications that the Administrator, as of the date of publication,
has--
(1) determined may be safely prescribed to or purchased
over-the-counter by an applicant for medical certification or
medical clearance to treat medical conditions; and
(2) approved for purposes of the issuance of a medical
certification or medical clearance to--
(A) an airman who requires a medical certificate or
a medical clearance; or
(B) an air traffic control specialist who requires
medical clearance.
(c) Requirements.--To ensure information transparency, user-
friendliness, and appropriate dissemination, the list required under
subsection (b) shall--
(1) incorporate, prior to dissemination, consultation
with--
(A) the Aeromedical Innovation and Modernization
Working Group (established under section 411(a) of the
FAA Reauthorization Act of 2024 (49 U.S.C. 44703 note))
(in this section referred to as the ``Working Group'');
(B) organizations representing collective
bargaining representatives of airline pilots;
(C) the certified exclusive bargaining
representatives of air traffic controllers of the FAA
certified under section 7111 of title 5, United States
Code;
(D) institutions of higher education that are
accredited by the Aviation Accreditation Board
International;
(E) professional pilot flight training schools
certified under part 141 of title 14, Code of Federal
Regulations;
(F) the Civil Aviation Medical Association;
(G) organizations representing general aviation
operators and pilots; and
(H) any other stakeholder determined relevant by
the Administrator;
(2) regarding treatment of medical conditions that may
impact the performance of duties or the exercise of privileges
of an airman certificate, include--
(A) medications allowed by the Administrator,
including prescription medications and over-the-counter
medications;
(B) contra-indications associated with the
medications described in subparagraph (A); and
(C) whether such medications may require review by
the FAA;
(3) be drafted in a user-friendly and accessible manner
and, in addition to being made publicly available pursuant to
subsection (b), made available on MedXPress for airmen, air
traffic control specialists, and individuals training to become
airmen or air traffic control specialists at the time when any
such individual first seeks a medical certification or medical
clearance;
(4) if practicable, indicate the minimum period of time an
airman, air traffic control specialist, or individual training
to become an airman or air traffic control specialist is
required to have limited or no duties to stabilize on a
medication allowed by the Administrator;
(5) include the list of medications that the Administrator
has designated as ``Do Not Issue'' or ``Do Not Fly'';
(6) include information for doctors or medical providers to
contact the FAA regarding questions related to the list
published under subsection (b), including through a new or
existing mechanism that is accessible to such doctors and
medical providers; and
(7) include any other information or clarification that the
Administrator determines appropriate.
(d) List Update.--Not later than 1 year after the date of
publication of the list required under subsection (b), and when
relevant information in the Guide for Aviation Medical Examiners (or
any successor document) or other relevant FAA medical certification
policy is updated, the Administrator shall update such list, as
appropriate.
(e) Savings Clause.--The publication of the list described in
subsection (b) shall not be construed as assigning liability to the
Administrator for any situation in which an airman, air traffic control
specialist, or applicant relies on such list in deciding whether to use
a medication on the list and--
(1) experiences an adverse medical reaction from the use of
such medication;
(2) causes harm or injury to persons or property after
using such medication; or
(3) is deemed by an aviation medical examiner or the FAA to
be ineligible for a medical certification or medical clearance.
Calendar No. 559
119th CONGRESS
2d Session
S. 3258
[Report No. 119-140]
_______________________________________________________________________
A BILL
To require the Administrator of the Federal Aviation Administration to
publish the list of medications that the Administrator has compiled for
purposes of the medical certification of airmen and air traffic control
specialists, and for other purposes.
_______________________________________________________________________
September 14, 2026
Reported with an amendment